| 1 |
32606755 | MiR-124-3p.1 Sensitizes Ovarian Cancer Cells to Mitochondrial Apoptosis Induced by Carboplatin. | 2020 |
1 |
| 2 |
27080533 | Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells. | 2016 Apr 14 |
1 |
| 3 |
21169413 | The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas. | 2011 Feb 1 |
2 |
| 4 |
20100569 | Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. | 2010 Jun |
1 |
| 5 |
20585448 | Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma. | 2010 Jun 18 |
3 |
| 6 |
18324624 | Transient ectopic expression as a method to detect genes conferring drug resistance. | 2008 Jun 1 |
1 |
| 7 |
18056200 | The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin. | 2007 Dec 1 |
2 |
| 8 |
11929841 | Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. | 2002 Apr 1 |
1 |
| 9 |
12570053 | BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin. | 2002 Dec |
6 |
| 10 |
10793331 | Cleavage of Bax-alpha and Bcl-x(L) during carboplatin-mediated apoptosis in squamous cell carcinoma cell line. | 2000 May |
7 |